ClearRead CT vs Stethee Pro 1
AI Verdict
Choose ClearRead CT if…
Choose ClearRead CT if your radiology department needs to enhance the accuracy and efficiency of pulmonary nodule detection and coronary artery calcification analysis from CT scans. This tool is ideal for integrating AI-driven insights directly into your existing PACS workflow, aiming to reduce reading times and improve the detection of actionable nodules.
View ClearRead CT →Choose Stethee Pro 1 if…
Choose Stethee Pro 1 if you require a portable, AI-enabled digital stethoscope for real-time cardiac and respiratory vital sign analysis, particularly in telemedicine or remote monitoring scenarios. This system is best suited for clinicians needing advanced auscultation capabilities, secure data sharing, and immediate AI-driven insights on the go.
View Stethee Pro 1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ClearRead CT | Stethee Pro 1 |
|---|---|---|
| Pricing | Contact for pricing | $499 usd |
| Deployment | On-premise (stand-alone server, virtual machine) and Cloud | Cloud, Mobile |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT (Tool A) offers seamless PACS integration and vendor-neutral processing, directly streamlining existing radiology workflows and reducing reading times by up to 36%. This deep integration into established clinical systems provides a highly efficient and familiar user experience for radiologists. While Stethee Pro 1 (Tool B) offers a mobile app and web portal, Tool A's direct impact on workflow efficiency within a high-volume environment gives it an edge in usability for its target audience.
Clinical Value
ClearRead CTClearRead CT (Tool A) demonstrates significant clinical value by improving diagnostic accuracy and achieving a 29% reduction in missed actionable pulmonary nodules, crucial for early detection of lung cancer and other conditions. It also provides automated nodule tracking and coronary artery calcification scoring, directly impacting patient care and outcomes. Stethee Pro 1 (Tool B) offers real-time vital sign analysis, but Tool A's quantifiable impact on reducing diagnostic errors for critical conditions makes its clinical value more pronounced.
Pricing & Value
Stethee Pro 1Stethee Pro 1 (Tool B) provides transparent pricing, clearly stating the device cost at $499 and indicating a subscription for its web portal. This allows potential buyers to understand the investment upfront. In contrast, ClearRead CT (Tool A) requires contacting the vendor for pricing details, making it difficult to assess its value proposition without further engagement.
Enterprise Readiness
ClearRead CTClearRead CT (Tool A) exhibits stronger enterprise readiness with its flexible deployment options, including on-premise (stand-alone server, virtual machine) and cloud, alongside seamless PACS integration. Its operation within institutions like the VA suggests proven capability for large-scale deployment and integration into complex healthcare IT environments. Stethee Pro 1 (Tool B), while cloud-based and mobile, does not detail the same level of integration into core hospital systems.
Innovation
Stethee Pro 1Stethee Pro 1 (Tool B) stands out as more innovative by claiming to be 'The World's First AI-Enabled Wireless Stethoscope System'. It integrates advanced features like sophisticated sound amplification, proprietary digital filters, and automatic geo-location with environmental data tagging into a traditional diagnostic tool, representing a significant re-imagining of the stethoscope. While ClearRead CT (Tool A) offers advanced AI in radiology with patented vessel suppression, Tool B's disruptive approach to a fundamental medical device is arguably more groundbreaking.
Support & Docs
TieBoth tools lack specific details regarding the depth and accessibility of their support and documentation within the provided facts. While web searches indicate both companies have dedicated support sections on their websites, neither provides enough granular information about service level agreements, comprehensive documentation, or specific support channels to definitively pick a winner. Therefore, based on the available information, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ClearRead CT | Stethee Pro 1 |
|---|---|---|
| Name | ClearRead CT | Stethee Pro 1 |
| Company | RIVERAIN TECHNOLOGIES | M3DICINE Pty Ltd. |
| Description | FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. | FDA-cleared, AI-enabled wireless digital stethoscope system, providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing. |
| Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Emergency Medicine, Pulmonology |
| Key Features (Primary Function) | Pulmonary Nodule Detection, Patented Vessel Suppression, Nodule Characterization and Measurement, Automated Nodule Tracking, Coronary Artery Calcification (CAC) Scoring. | AI-enabled wireless digital stethoscope, Captures cardiac and respiratory vital signs in 20 seconds, Sophisticated sound amplification, Real-time visualization of heart and lung sounds. |
Videos
Demos, reviews, and walkthroughs featuring ClearRead CT and Stethee Pro 1.